References
Aggerholm-Pedersen N, Maretty-Nielsen K, Keller J, Baerentzen S, Safwat A. Comorbidity in adult bone sarcoma patients: A population-based cohort study. Sarcoma. 2014;2014:690316–9.
Al-Refaie WB, Habermann EB, Dudeja V, Vickers SM, Tuttle TM, Jensen EH, Virnig BA. Extremity soft tissue sarcoma care in the elderly: Insights into the generalizability of NCI Cancer Trials. Ann Surg Oncol. 2010;17:1732–1738.
Alibhai SMH, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer? Cancer. 2008;112:1043–1050.
Boden RA, Clark MA, Neuhaus SJ, A’hern JR, Thomas JM, Hayes AJ. Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol. 2006;32:1154–1158.
Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat M-C, Daurès J-P, Pujol J-L, oncoLR health network. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: Description and comparison with the Charlson’s index. Br J Cancer. 2005;93:1098–1105.
De Rui M, Veronese N, Manzato E, Sergi G. Role of comprehensive geriatric assessment in the management of osteoporotic hip fracture in the elderly: An overview. Disabil Rehabil. 2013;35:758–765.
Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW, Han M. Prediction of mortality after radical prostatectomy by Charlson Comorbidity Index. Urology. 2010;76:553–557.
Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004;4:94.
Kennedy JW, Johnston L, Cochrane L, Boscainos PJ. Outcomes of total hip arthroplasty in the octogenarian population. Surgeon. 2013;11:199–204.
Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PWT, Pollock RE, Lev D. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009;16:2579–2586.
Mundi S, Pindiprolu B, Simunovic N, Bhandari M. Similar mortality rates in hip fracture patients over the past 31 years. Acta Orthopaedica. 2014;85:54–59.
Teng GG, Curtis JR, Saag KG. Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol. 2008;26:S125–37.
Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, Covinsky KE. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA. 2001;285:2987–2994.
Author information
Authors and Affiliations
Corresponding author
Additional information
This CORR Insights® is a commentary on the article “What Is the Effect of Advanced Age and Comorbidity on Postoperative Morbidity and Mortality After Musculoskeletal Tumor Surgery?” by Ogura and colleagues available at: DOI: 10.1007/s11999-014-3889-y.
The author certifies that he, or any member of his immediate family, has no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research ® editors and board members are on file with the publication and can be viewed on request.
The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR ® or the Association of Bone and Joint Surgeons®.
This CORR Insights® comment refers to the article available at DOI: 10.1007/s11999-014-3889-y.
About this article
Cite this article
Wodajo, F.M. CORR Insights®: What Is the Effect of Advanced Age and Comorbidity on Postoperative Morbidity and Mortality After Musculoskeletal Tumor Surgery?. Clin Orthop Relat Res 472, 3979–3981 (2014). https://doi.org/10.1007/s11999-014-3951-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-014-3951-9